Welcome to our dedicated page for Myomo SEC filings (Ticker: MYO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Myomo Inc. filings document material events for a Delaware medical-device company focused on wearable robotics and the MyoPro powered upper-limb orthosis. Recent Form 8-K disclosures furnish quarterly and annual operating results, revenue sources, MyoPro orders and authorizations, patient-pipeline activity, and exhibits tied to financial press releases.
The filing record also covers governance and capital-structure matters, including board appointments, director compensation arrangements, indemnification agreements, and loan and security agreements. These disclosures describe formal reporting of operating performance, financing terms, corporate governance actions and related risk and control subjects for MYO.
MYOMO, INC. Chief Medical Officer Harry Kovelman reported a Form 4 transaction where 10,442 shares of Common Stock were sold at $1.20 per share on June 12, 2026. According to the footnote, these shares were sold solely to pay income taxes from restricted stock units that vested on June 11, 2026, under an earlier irrevocable election. After this tax-withholding disposition, Kovelman directly owns 90,541 shares.
MYOMO, INC. Chief Commercial Officer Micah Mitchell reported a tax-related share disposition. On June 12, 2026, 9,061 shares of common stock at $1.20 per share were delivered to cover income taxes arising from restricted stock units that vested on June 11, 2026, under a prior irrevocable election. Following this transaction, he holds 93,888 shares of common stock directly.
MYOMO, INC. Chief Financial Officer David A. Henry reported a routine tax-related share disposition. On June 12, 2026, 10,969 shares of common stock were withheld to cover income taxes arising from restricted stock units that vested on June 11, 2026. This was an automatic tax-withholding event, not an open-market sale. After the withholding, Henry directly holds 424,155 shares of Myomo common stock.
Myomo, Inc. reports a Form 144 notice for proposed resale activity following the vesting of 20,979 restricted stock units on 06/11/2026. The filing also lists recent dispositions by Harry Kovelman: 7,635 shares on 06/08/2026, 11,536 shares on 05/28/2026, and 20,464 shares on 05/27/2026.
Myomo, Inc. reports Rule 144 notices and RSU vesting. The filing lists 19,813 shares tied to the vesting of Restricted Stock Units on 06/12/2026. It also records past sales by Micah Mitchell: 6,529 shares on 06/08/2026 and 90,231 shares on 05/14/2026.
This Form 144 excerpt lists the securities type as Common Stock and identifies the broker as Morgan Stanley Smith Barney LLC.
MYOMO, INC. Chief Commercial Officer Micah Mitchell reported a compensation-related share disposition. On the vesting of restricted stock units, 6,529 shares of common stock were delivered on June 8, 2026 solely to cover income taxes at $1.33 per share. After this tax-withholding event, Mitchell directly holds 102,949 MYO shares.
MYOMO, INC. Chief Medical Officer Harry Kovelman reported a routine tax-related share disposition. On June 8, 2026, 7,635 shares of common stock were sold at $1.33 per share solely to cover income taxes from restricted stock units that vested on June 5, 2026. After this transaction, he directly holds 100,983 shares.
MYOMO, INC. Chief Financial Officer David A. Henry had 10,050 shares of common stock withheld on June 8, 2026 to cover income taxes from restricted stock units that vested on June 5, 2026. After this tax-withholding disposition, he directly holds 435,124 shares of MYO common stock.
MYOMO, INC. director F. Kirk Thomas reported an open-market purchase of 40,002 shares of common stock on June 5, 2026 at a weighted average price of $1.27 per share. The filing notes the shares were bought in multiple lots at prices ranging from $1.23 to $1.30 per share. Following this transaction, Thomas directly owns 693,865 shares of Myomo common stock.
MYOMO, INC. Chief Commercial Officer Micah Mitchell sold 90,231 shares of common stock in open-market transactions on May 14, 2026. The weighted average sale price was $0.861 per share, with individual lots ranging from $0.85 to $0.889 per share. After these sales, Mitchell directly holds 109,478 shares of MYOMO common stock.